This company has been marked as potentially delisted and may not be actively trading. Anzu Special Acquisition Corp I (ANZU) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock ANZU vs. MLSS, APT, LGMK, AHPI, ENTX, OCX, ZNTL, MBOT, ADAG, and FONRShould you be buying Anzu Special Acquisition Corp I stock or one of its competitors? The main competitors of Anzu Special Acquisition Corp I include Milestone Scientific (MLSS), Alpha Pro Tech (APT), LogicMark (LGMK), Allied Healthcare Products (AHPI), Entera Bio (ENTX), OncoCyte (OCX), Zentalis Pharmaceuticals (ZNTL), Microbot Medical (MBOT), Adagene (ADAG), and Fonar (FONR). Anzu Special Acquisition Corp I vs. Its Competitors Milestone Scientific Alpha Pro Tech LogicMark Allied Healthcare Products Entera Bio OncoCyte Zentalis Pharmaceuticals Microbot Medical Adagene Fonar Milestone Scientific (NYSE:MLSS) and Anzu Special Acquisition Corp I (NASDAQ:ANZU) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings. Does the media prefer MLSS or ANZU? In the previous week, Milestone Scientific had 5 more articles in the media than Anzu Special Acquisition Corp I. MarketBeat recorded 5 mentions for Milestone Scientific and 0 mentions for Anzu Special Acquisition Corp I. Anzu Special Acquisition Corp I's average media sentiment score of 0.44 beat Milestone Scientific's score of -0.71 indicating that Anzu Special Acquisition Corp I is being referred to more favorably in the news media. Company Overall Sentiment Milestone Scientific Negative Anzu Special Acquisition Corp I Neutral Which has more risk and volatility, MLSS or ANZU? Milestone Scientific has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, Anzu Special Acquisition Corp I has a beta of 0.03, meaning that its stock price is 97% less volatile than the S&P 500. Which has higher earnings & valuation, MLSS or ANZU? Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Milestone Scientific. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMilestone Scientific$8.61M6.10-$6.93M-$0.07-9.57Anzu Special Acquisition Corp IN/AN/A$19.23MN/AN/A Is MLSS or ANZU more profitable? Anzu Special Acquisition Corp I has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Anzu Special Acquisition Corp I's return on equity of -17.33% beat Milestone Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Milestone Scientific-52.01% -60.26% -40.23% Anzu Special Acquisition Corp I N/A -17.33%1.37% Do analysts prefer MLSS or ANZU? Milestone Scientific presently has a consensus target price of $1.25, suggesting a potential upside of 86.57%. Given Milestone Scientific's stronger consensus rating and higher possible upside, equities research analysts clearly believe Milestone Scientific is more favorable than Anzu Special Acquisition Corp I.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Anzu Special Acquisition Corp I 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders have more ownership in MLSS or ANZU? 5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 27.3% of Anzu Special Acquisition Corp I shares are owned by institutional investors. 24.8% of Milestone Scientific shares are owned by company insiders. Comparatively, 0.7% of Anzu Special Acquisition Corp I shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryMilestone Scientific beats Anzu Special Acquisition Corp I on 7 of the 13 factors compared between the two stocks. Get Anzu Special Acquisition Corp I News Delivered to You Automatically Sign up to receive the latest news and ratings for ANZU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANZU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANZU vs. The Competition Export to ExcelMetricAnzu Special Acquisition Corp ISurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$23.45M$28.19M$5.53B$9.05BDividend YieldN/AN/A5.24%4.03%P/E RatioN/A12.8427.5220.22Price / SalesN/A2.39421.02118.64Price / Cash3.7412.8036.8958.07Price / Book-0.932.338.045.67Net Income$19.23M-$5.31M$3.18B$249.13M Anzu Special Acquisition Corp I Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANZUAnzu Special Acquisition Corp IN/A$1.57+4.7%N/A-32.9%$23.45MN/A0.003MLSSMilestone Scientific2.96 of 5 stars$0.73-4.3%$1.25+71.9%+1.5%$57.05M$8.61M-10.3830Gap UpHigh Trading VolumeAPTAlpha Pro Tech1.6793 of 5 stars$4.73-0.2%N/A-16.1%$51.39M$58.18M12.78120LGMKLogicMark0.3055 of 5 stars$0.00-2.4%N/A-100.0%$2.31M$9.88M0.0020Gap UpAHPIAllied Healthcare ProductsN/AN/AN/AN/A$16K$27.05M0.00150Gap UpENTXEntera Bio2.626 of 5 stars$1.90-5.0%$10.00+426.3%+18.9%$90.90M$180K-7.3120Positive NewsOCXOncoCyte2.0298 of 5 stars$3.18+16.3%$6.06+90.9%+3.8%$90.80M$3.84M-0.90120ZNTLZentalis Pharmaceuticals1.5885 of 5 stars$1.18-6.3%$8.37+609.0%-64.1%$90.66M$67.43M-0.38160Gap UpHigh Trading VolumeMBOTMicrobot Medical2.1683 of 5 stars$2.50+0.4%$9.00+260.0%+147.6%$90.58MN/A-3.8520Positive NewsADAGAdagene2.0229 of 5 stars$1.95+2.6%$8.00+310.5%-35.0%$89.51M$100K0.00260FONRFonar0.7942 of 5 stars$14.88+3.2%N/A-1.6%$89.45M$102.88M11.90480 Related Companies and Tools Related Companies MLSS Competitors APT Competitors LGMK Competitors AHPI Competitors ENTX Competitors OCX Competitors ZNTL Competitors MBOT Competitors ADAG Competitors FONR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANZU) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anzu Special Acquisition Corp I Please log in to your account or sign up in order to add this asset to your watchlist. Share Anzu Special Acquisition Corp I With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
